Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CRL
EXEL
Add up to 3 more stocks
CRL
Charles River Laboratories International, Inc.
+1.28%
$295.19+3.74Delayed quote: Aug 21, 2026, 4:00 PM EDT
Market Cap
$14.22B
52W Range
$144.26 - $299.32
EXEL
Exelixis, Inc.
+0.73%
$54.08+0.39Delayed quote: Aug 21, 2026, 4:00 PM EDT
Market Cap
$13.59B
52W Range
$33.76 - $57.57
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 16.95 |
| Forward P/E | 25.75 | 18.14 |
| P/B Ratio | 4.98 | 7.62 |
| P/S Ratio | 3.53 | 5.77 |
| P/FCF Ratio | 38.13 | 11.89 |
| EV/EBITDA | 21.43 | 13.93 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 32.2% | 96.5% |
| Operating Margin | 12.3% | 39.9% |
| Net Margin | -6.0% | 35.3% |
| ROE | -8.4% | 46.7% |
| ROA | -3.2% | 34.5% |
| ROIC | 7.7% | 37.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.35 | 3.46 |
| Quick Ratio | 1.04 | 3.38 |
| Debt/Equity | 1.07 | 0.09 |
| Interest Coverage | 4.74 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.